onmed / OnMed

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: http://onmed.se/sitemap_index.xml # --------------------------- # END YOAST

Meta Tags

Title	OnMed
Description	Advanced Tumour A leader in Electrochemotherapy technology and electroporation therapies. Safe and effective advanced tumour therapy method based on electroporation. Gene therapy and related immunotherapy enhanced
Keywords	N/A

Server Information

WebSite	onmed.se
Host IP	93.188.2.53
Location	Sweden

Related Websites

                        Site
                        Rank
                    

More to Explore

rubberconsultants.com

bethanybeachtownhouse.com

holidayletsuccess.com

todaysprint.com

maccabuse.org

toomeyltd.com

idahoslargestgaragesale.com

albuquerquemailservice.com

onmed.se Valuation

US$1,338,619

Last updated: 2023-05-16 14:14:45

onmed.se has Semrush global rank of 7,906,883. onmed.se has an estimated worth of US$ 1,338,619, based on its estimated Ads revenue. onmed.se receives approximately 154,457 unique visitors each day. Its web server is located in Sweden, with IP address 93.188.2.53. According to SiteAdvisor, onmed.se is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,338,619
Daily Ads Revenue	US$1,236
Monthly Ads Revenue	US$37,070
Yearly Ads Revenue	US$444,834
Daily Unique Visitors	10,298
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
onmed.se.	A	553	IP: 93.188.2.53
onmed.se.	AAAA	550	IPV6: 2a02:250:0:8::51
onmed.se.	NS	3600	NS Record: ns1.loopia.se.
onmed.se.	NS	3600	NS Record: ns2.loopia.se.
onmed.se.	MX	3600	MX Record: 1 onmed-se.mail.protection.outlook.com.
onmed.se.	TXT	3600	TXT Record: ms=ms42109892
onmed.se.	TXT	3600	TXT Record: v=spf1 include:outlook.com ~all

HtmlToTextCheckTime:2023-05-16 14:14:45

Home Electrochemotherapy Sennex About Us News & Updates Contact Menu Home Electrochemotherapy Sennex About Us News & Updates Contact A leader in Electrochemotherapy technology Enhanced drug delivery method with short, high voltage pulses. Usually takes 20-30 minutes. Can be done under local anaesthesia. Can be used in combination with chemotherapy, radiotherapy and surgery. Safe and simple procedure following guidelines. Normally, only mild side-effects are seen after treatment. Reduced bleeding and secretions often seen in 48 hours. Tumor regression is achieved in 2 to 4 weeks. High rate of response for various tumor types. CTA.LABEL Bibliography-Scientific evidence articles Where and When to Use SENNEX? SENNEX ® Electrochemotherapy (ECT) is a local palliative treatment modality. It is recommended for treatment of cutaneous and subcutaneous metastases independent of the primary tumor type. Read More Device and Certification The SENNEX ® system with Electroporation (ECT) device is

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sat, 29 Jan 2022 10:51:21 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Powered-By: PHP/7.4.25
X-Redirect-By: WordPress
Location: https://onmed.se/
X-Loopia-Node: 172.22.223.33

HTTP/2 200 
server: nginx
date: Sat, 29 Jan 2022 10:51:22 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
x-powered-by: PHP/7.4.25
set-cookie: PHPSESSID=d36cc29f20c79f306a7f6b2c6febaaf0; path=/
expires: Thu, 19 Nov 1981 08:52:00 GMT
cache-control: no-store, no-cache, must-revalidate
pragma: no-cache
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-loopia-node: 172.22.223.33

onmed.se Whois Information

#
state:            active
domain:           onmed.se
holder:           tomonm8339-00001
created:          2013-09-06
modified:         2021-07-01
expires:          2022-09-06
transferred:      2015-08-07
nserver:          ns1.loopia.se 93.188.0.20
nserver:          ns2.loopia.se 93.188.0.21 2a02:250:ffff::21
dnssec:           signed delegation
registry-lock:    unlocked
status:           ok
registrar:        Loopia AB

onmed.se valuation and analysis